Welcome to Molecular Therapy

Molecular Therapy is the official journal of the American Society for Gene Therapy. Available in print and online, Molecular Therapy is dedicated to publishing important peer-reviewed research and cutting-edge reviews and promoting the sciences in genetics, medicine and biotechnology.


Free for everyone. Molecular Therapy Editorials and In This Issue are too good to keep to only our subscribers. They are now available to everyone. Learn more about the world of molecular therapy by reading the latest issue.

About the cover Free online issue

Volume 16, No 7
July 2008

ISSN: 1525-0016
EISSN: 1525-0024

Impact Factor 5.862*
8/138 in Biotechnology and Applied Microbiology
17/132 in Genetics and Heredity
7/81 in Medicine, Research and Experimental

Editor-in-Chief:
David A Williams

*2007 Journal Citation Report (Thomson Reuters, 2008)

NEWS

Gene therapy harboring freeze-dried tendons could help repair damaged tendons. As seen on BBC News and MSNBC, scientists have used rAAV-GDF5 vectors to reduce adhesion formation and enable the proper integration of freeze-dried tendon allografts. Read the article published in Molecular Therapy for free and find out more about this advancement.

The ASGT celebrated its 10th anniversary at the annual meeting in Seattle, Washington from May 30 - June 3, 2007. Find out more at the ASGT annual meeting website. Did you miss the meeting? Read the ASGT meeting abstracts here!

Perfect placement. Molecular Therapy encourages authors to submit figures and artwork for the journal's cover - a prime position to gain great exposure for your research. Gene or stem cell-related images are especially of interest. For more information on image requirements, download the cover specifications sheet.

Read some of the top cited articles in Molecular Therapy free!

Design of Noninflammatory Synthetic siRNA Mediating Potent Gene Silencing In Vivo

Genotoxicity of Retroviral Integration in Hematopoietic Cells

A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen-Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate Cancer

Quantitative Comparison of Intracellular Trafficking and Nuclear Transcription between Adenoviral and Lipoplex Systems

Gene Therapy for Lysosomal Storage Diseases

Silencing of HIV-1 with RNA Interference: A Multiple shRNA Approach

Extra navigation

24 July 2008

naturejobs

ADVERTISEMENT